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Short Report
Magnetic Resonance Imaging (MRI) findings in White Matter Disease of Brain
Humera Ahsan, Muhammad Zafar Rafique, Fozia Ajmal, Mohsin Wahid, Muhammad Azeemuddin, Farah Iqbal
Department of Radiology, Aga Khan University Hospital, Karachi.
Abstract
Demyelinating and dysmyelinating white matter
diseases are important components of neurological
problems. Recently, Magnetic Resonance Imaging (MRI)
has played a key role in diagnoses of white matter diseases.
Therefore, the purpose of the current study is to evaluate the
usefulness of MRI in determining the type and frequency of
white matter disease.
We studied 35 patients who visited the Radiology
Department of the Aga Khan University Hospital (AKUH)
for MRI with suspected demyelinating/dysmyelinating
disorder from January 2003 to December 2005. Multiple
Sclerosis (MS) (17; 48%) and leukodystrophies (10; 29%)
were the most common diseases.
The MRI helped identify the sites and types of the
lesion precisely and thereby. helped made clearer.
distinction between various types of white matter diseases.
The current study demonstrated the effective use of the
imaging and clinical presentation for arriving at the correct
diagnosis.
Introduction
Demyelinating and dysmyelinating white matter
diseases are important components of neurological
problems. White matter diseases include Multiple Sclerosis
(MS), Leukodystrophies, Central Pontine Myelinolysis,
Acute Disseminated Encephalomyelitis and Progressive
Multifocal Leukoencephalopathy. MS is the commonest of
all the white matter diseases.1 Leukodystrophies, which
include Disseminated Encephalomyelitis (ADEM)2,
Central Pontine Myelinolysis3,4 and Progressive Multifocal
Leukoencephalopathy, are ranked second.5,6
With the ever rising burden of the white matter
disease, it is imperative to better understand patho-
physiological, clinical and imaging findings for proper
management of patients. The advent of Magnetic
Resonance Imaging (MRI) has revolutionized the concept
of diagnosing and understanding of white matter diseases.1
Many of the white matter diseases, if detected early,
can be cured and MRI plays a vital role in its early
diagnosis.7 MRI is considered far superior to Computed
Tomography (CT) and the imaging modality of choice in
white matter diseases. CT does not detect subtle lesions
especially in stages of clinical inactivity and is not ideal in
posterior fossa imaging due to the beam hardening
artifacts.8 The multiplanar imaging capability and very high
sensitivity for demyelinating foci due to its excellent gray-
white matter resolution make MRI imaging the modality of
choice.9 Through MRI, simultaneous imaging of spinal cord
and orbits can also be done. Moreover, with the advent of
multi-echo sequences of MR, even subtle lesions of
demyelination can be detected.10
The purpose of the current study is to evaluate the
frequency of white matter disease among suspected cases of
demyelinating disorders in our setting. Further the study
will also look into use of MR imaging features in diagnosis
of white matter disease and relate it with clinical findings.
Patients, Methods and Results
We conducted a descriptive study of the patients who
had their MRI brain done with clinical suspicion of
demyelinating disorder at the Radiology Department of The
Aga Khan University Hospital (AKUH) from January 2003
to December 2005.
Forty eight patients visited the department during the
study period. However, thirteen were excluded due to prior
diagnosis of white matter disease and/or incomplete
medical records. Thirty five patients were finally included
in the study. The MRI examination features of these patients
were highly suggestive of demyelinating or dysmyelinating
diseases.
All the patients were examined with 1.5 Tesla
systems (Toshiba Medical System). Head coil was used in
all the patients. A combination of T1 and T2 weighted and
FLAIR sequences and post gadolinium T1 weighted was
obtained in each patient. 
Each MR image was interpreted by two Radiologists
proficient in reporting brain MRI. In case of difference of
opinion, consensus was developed through discussion
between the two radiologists.
The diagnosis was confirmed by laboratory findings
of CSF oligoclonal band in patients with MS. Among cases of
acute disseminated encephalomyelitis and leukodystrophies,
the diagnosis was established through typical imaging
findings and clinical course without any relapse. MRI
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features of all the patients are shown in Table. 
Our study included 35 patients of white matter
diseases: 14 (40%) males and 21 (60%) females. The
majority of patients suffered from MS 17 (48%): 10
(58.8%) females and 7 (41.2%) males with average ages of
32 and 31 years respectively. MRI revealed multiple lesions
confined to the white matter appearing hypo-intense on
T1W and hyper-intense on T2W images. In all the patients
at least three or more lesions were seen. The majority of the
lesions were less than one cm. in size. The commonest sites
of involvement were the periventricular and pericallosal
area (Figures1a and b).  The other sites were centrum semi-
ovale, deep white matter and sub cortical white matter of
left frontal lobe, parietal lobe, parieto-occipital region, left
temporal lobe, cervical spinal cord, right pons and posterior
part of left optic nerve. 
Leukodystrophies, which include Metachromatic
Leukodystrophy and Adrenoleukodystrophy, Alexender's
and Niemen Pick Diseases, were the other most common
group of white matter diseases. The results showed that 10
(28.6%) patients, 7 (70%) males and 3 (30%) females,
suffered form leukodystrophies. Each type of
leukodystrophy presented with different frequencies and
MRI findings.
Three patients, all males with an average age of 4
years, suffered from metachromatic leukodystrophy. The
commonest site was periventricular white matter. On the
other hand, adrenoleukodystrophy was seen in three
patients. The average age was three years. The abnormal
signals of deep periventricular white matter specifically in
trigonal area with ventriculomegaly were observed in two
out of three patients. 
Leigh disease was diagnosed in two cases. The MR
showed hyperintense signal on T2 weighted images in deep
grey matter nuclei, tegmentum thalami, periventricular
white matter, periequiductal region and dentate nuclei. 
One patient showed signs of Alexander's disease.
The MRI showed periventricular hyperintensity in the
frontal white matter with a cyst in the third ventricle and
post contrast periventricular enhancement. Similarly, one
patient had Niemen Pick Disease. MRI showed Gliosis in
the frontal and temporal lobes
The Central Pontine Myelinosis was ranked third
among the white matter diseases identified. Three (8.5%)
patients, two males and one female, had the disease.  T2
signal changes were seen in the pons in all cases on MRI. 
One male patient suffered from Progressive
Multifocal Leukoencephalopathy. He was 30 years old and
tested positive for Human Immunodeficiency Virus (HIV).
MRI showed abnormal signal intensity in deep white matter
of brain in right frontal regions, parietooccipital regions,
putamen and midbrain. The signals were isointense on T1
and hyperintense on T2 weighed images.
Acute Disseminated Encephalomyelitis was
identified in four patients.  T2 weighted and FLAIR images
1a. 1b.
Figure 1: MRI of the brain, (a) Sagittal Flair and (b) Axial T2 weighted images, in a case of
Multiple Sclerosis showing typical periventricular and pericollosal location of the lesions.
Table 1.  MR Imaging findings of various white matter diseases.
S.No Disease MR Imaging Findings
1. Multiple Sclerosis T2 and FLAIR hyperintensity in
pericallosal area white matter,
cervical spinal cord, pons and
posterior part optic nerve. 
2.1 Metachromatic
Leukodystrophy
T2 and FLAIR hyperintense
signal in periventricular white
matter in frontal and peritrigonal
area.
2.2 Leigh disease T2 and FLAIR hyperintensity in
deep grey matter nuclei,
tegmentum, thalami,
periventricular white matter,
periequiductal region and dentate
nuclei
2.3 Adrenoleukodystrophy T2 and FLAIR hyperintensity in
deep peritrigonal white matter,
Ventriculomegaly
2.4 Alexander's disease Periventricular hyperintensity in
the frontal lobe with post contrast
enhancement and a cyst in the
third ventricle 
2.5 Niemans Pick disease Subcortical Gliosis in the frontal
and Temporal lobe, brain atrophy.
3. Central Pontine Myelinolysis Hyperintense signal in the pons in
all cases and in the peripheral
portion of left putamen and in
head of caudate nucleus in one
case
4. Acute Disseminated
Encephalomyelitis
Asymmetrical hyperintense
signals in the subcortical white
matter of frontal, parietal and
occipital lobe and cerebellum
with enhancement on post
contrast scans.
5. Progressive Multifocal
Leukoencephalopathy
Abnormal signal in deep white
matter in frontal regions
parietooccipital regions, putamen
and midbrain
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showed asymmetrical hyperintense signals in the
subcortical white matter of frontal, parietal and occipital
lobe and cerebellum. 
Conclusion
The current study presents the proportion of patients
suffering from each type of white matter disease. It also
demonstrates the effective use of the imaging and clinical
presentation in making the right diagnosis.
White matter diseases are a heterogeneous group of
disorders, where the main imaging finding is the abnormal
white matter. Although a clinical diagnosis is usually
present in these disorders, imaging reinforces the diagnosis
in many cases. Thereby, MRI imaging could play a pivotal
role in prompt treatment of patients with white matter
disease.
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Short Report
An open study to assess the safety and efficacy of Heprovac-B vaccine 10 mcg-dose
for adults
Hasnain Ali Shah, S.M.Wasim Jafri
Department of Medicine,The Aga Khan University Hospital, Karachi.
Abstract
Heprovac B is a novel recombinant vaccine There are
many vaccines available in Pakistani market but Heprovac B
claims to be immunogenic even at 10 meg dose.Aim of the
study is to determine whether using 10 meg of Heprovac B
vaccine is safe and effective in producing sufficient
immunity in Pakistani population. One hundred and twenty
five subjects, who fulfilled the Inclusion criteria, were
enrolled for the study. Heprovac B was administered in a
three-dose regimen given at 0, 1 and 6 months and adverse
events were recorded. Immunogenicity was tested by
measuring hepatitis B surface antibody one month after each
dose received.One month after the 3rd dose 98.7% of the
subjects were found to be seroprotected with geometric
mean titer of 488.83 mIU/1 after the third dose. Heprovac B,
vaccine was well tolerated with minimal reported adverse
events. It is safe and 10mcg is immunogenic in producing
antibodies in Pakistani population against Hepatitis B virus.
Introduction
Hepatitis B virus infection is a major healthcare
issue that affects children and adults worldwide. Long term
infection can lead to chronic hepatitis, cirrhosis and primary
hepatocellular carcinoma.1 In Pakistan, Hepatitis B is one of
the major causes of chronic liver disease and hepatocellular
carcinoma. In Pakistan, the estimate is 4.5 million carriers,
with a carrier rate of 3-4%.2
Since, there is no definite treatment available yet,
great emphasis is being placed on its prevention through
immunization.3 Currently there are yeast derived vaccines
present in Pakistan. The immunogenicity of these vaccines
has been subjected to intense study since their birth. 
There are three forms of HBsAg that are expressed
in the hepatitis B vaccine, namely the major form consisting
of the S protein alone, the large form containing the preS1 -
preS2 - S components and a middle form containing pre S2
- S components. The presence of these conforms to the
Immunogenicity of the vaccine.4 The yeast cell recombinant
vaccines contain only the major form i.e. only protein S;
hence chances of failure of sero-conversion in these
vaccines does exist. 
The CHO cell derived vaccine, on the other hand,
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